Methotrexate-induced lymphoproliferative disease: Epstein-Barr virus-associated lymphomatoid granulomatosis

Journal of Clinical Oncology

Volumn 31, Issue 20, 2013, Pages

  Ochi, Nobuaki ^a   Yamane, Hiromichi ^a   Yamagishi, Tomoko ^a   Monobe, Yasumasa ^a   Takigawa, Nagio ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; IMMUNOGLOBULIN G; METHOTREXATE; CONTRAST MEDIUM; DIAGNOSTIC AGENT;

AGED; ARTICLE; B LYMPHOCYTE; BRONCHOSCOPY; CASE REPORT; CELL TRANSFORMATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS INFECTION; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LUNG ANGIOGRAPHY; LUNG BIOPSY; LUNG TUMOR; LYMPHOCYTIC INFILTRATION; LYMPHOMATOID GRANULOMATOSIS; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; THORAX RADIOGRAPHY; TREATMENT DURATION; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; EPSTEIN BARR VIRUS; FOLLOW UP; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; METHODOLOGY; NEEDLE BIOPSY; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; VIROLOGY;

AGED; ARTHRITIS, RHEUMATOID; BIOPSY, NEEDLE; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHOMATOID GRANULOMATOSIS; METHOTREXATE; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84883879588     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.46.2770     Document Type: Article

References (9)

1. Hoshida Y, Xu JX, Fujita S, et al: Lymphoproliferative disorders in rheumatoid arthritis: Clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol 34:322-331, 2007
2. Swerdlow SH, Campo E, Harris NL, et al (eds): WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues. Lyon, France, International Agency for Research on Cancer, 2008, pp 247-249
3. Wilson WH, Kingma DW, Raffeld M, et al: Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b. Blood 87:4531-4537, 1996
4. Dawson TM, Starkebaum G, Wood BL, et al: Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: Case series. J Rheumatol 28:47-53, 2001
5. Myers JL, Kurtin PJ, Katzenstein AL, et al: Lymphomatoid granulomatosis: Evidence of immunophenotypic diversity and relationship to Epstein-Barr virus infection. Am J Surg Pathol 19:1300-1312, 1995
6. Starzl TE, Nalesnik MA, Porter KA, et al: Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1:583-587, 1984
7. Kamel OW, van de Rijn M, Weiss LM, et al: Brief report: Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 328:1317-1321, 1993
8. Salloum E, Cooper DL, Howe G, et al: Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 14:1943-1949, 1996
9. Hoshida Y, Tomita Y, Zhiming D, et al: Lymphoproliferative disorders in autoimmune diseases in Japan: Analysis of clinicopathological features and Epstein-Barr virus infection. Int J Cancer 108:443-449, 2004